ABOUT MEDCAP OPERATION INVESTOR CORPORATE GOVERNANCE PRESS & MEDIA WE CREATE VALUE IN LIFE SCIENCE MedCap develops leading niche companies in Life Science MedCap's business concept is to acquire and develop small and medium-sized, well-managed Life Science companies by contributing capital, expertise, experience and networks within each company's business area. Ownership is in most cases long-term and is exercised actively, professionally and with a sense of corporate traditions. About MedCap PRESS RELEASES 2021-11-08 13:00 NOTICE OF EXTRAORDINARY GENERAL MEETING IN MEDCAP AB (PUBL) 2021-10-29 04:30 EBITDA increased by 24 percent in the third quarter 2021-10-15 06:30 Nomination committee in MedCap appointed Press releases CALENDAR FEB 10 Year-end report 2021 06 MAY Interim report 1 2022 09 MAY Annual General Meeting 2022 To calendar Latest interim report Läs MedCaps delårsrapport för tredje kvartalet 2021, se länk nedan. Till delårsrapport AKTIEN 25 nov 2021 17:24 176,80 SEK 0,00 SEK Till aktien Våra bolag Verksamheten bedrivs inom två områden, medicinteknik och specialistläkemedel. Sedan 2001 har MedCap genomfört förvärv, refinansieringar och försäljningar. Abilia Cardiolex Inpac Multi-Ply Unimedic Read more about our holdings Become part of MedCap Here you will find more information about our investment strategy and about MedCap as owner. Investment strategy MedCap as owner ABOUT MEDCAP OPERATION INVESTOR CORPORATE GOVERNANCE PRESS & MEDIA CONTACT GDPR SV / EN MEDCAP AB | RÅSUNDAVÄGEN 6 | 169 67 SOLNA +46 8 34 71 10 INFO@MEDCAP.SE

OM MEDCAP VERKSAMHET INVESTERARE BOLAGSSTYRNING PRESS & MEDIA KALENDARIUM START INVESTERARE KALENDARIUM Kalendarium KALENDER 10 FEB Bokslutskommuniké 2021 06 MAJ Delårsrapport 1 2022 09 MAJ Årsstämma 2022 29 JUL Delårsrapport 2 2022 28 OKT Delårsrapport 3 2022 OM MEDCAP VERKSAMHET INVESTERARE BOLAGSSTYRNING PRESS & MEDIA KONTAKT GDPR SV / EN MEDCAP AB | RÅSUNDAVÄGEN 6 | 169 67 SOLNA +46 8 34 71 10 INFO@MEDCAP.SE